Tandem Diabetes Care, Inc. (TNDM) — Fair Value Analysis
Base-case fair value (P50): $19.07 · Current price: $15.47 · Verdict: Undervalued
The Verdict on TNDM
Our latest Monte Carlo simulations indicate TANDEM DIABETES CARE INC (TNDM) is currently undervalued. With a current price of $15.47, our median fair value (P50) stands at $19.07, suggesting a potential upside of +23.3%. This assessment, derived from thousands of simulated forward scenarios, points to a clear disconnect between TNDM's market valuation and its intrinsic worth. The statistical modeling suggests a notable margin of safety at the current price, countering any assertion that TNDM is overvalued based on this rigorous analysis.
How TNDM stacks up against peers
TNDM's operational and financial health is currently rated as 'average' when benchmarked against its sector peers. This 'average' quality tier, however, does not detract from the undervaluation identified by our comprehensive Monte Carlo analysis. An 'average' quality firm trading at a current price of $15.47 below its calculated fair value of $19.07 suggests the market might be overlooking its true potential. Investors should consider how this average standing, coupled with the substantial +23.3% implied upside, strategically positions TNDM within its competitive landscape.
What this means for investors
For investors closely following TNDM, the current analysis points to a compelling entry point, with the current price of $15.47 residing significantly below the median fair value of $19.07. While our 'average' quality tier suggests operational strengths are not exceptional, the robust +23.3% implied upside indicates a clear statistical advantage. A downside scenario, while always a consideration, is balanced by the strong upside implied by our Monte Carlo results. The overall fair value assessment, indicating TNDM as undervalued, warrants further investigation into both the potential bull and bear cases. FairCurve's analytical methodology underpins this objective perspective. Unlock the full bear and bull distribution and track TNDM's fair value as new fundamentals are released by signing up for FairCurve.
Frequently Asked Questions
Is TNDM overvalued or undervalued right now?
Based on our Monte Carlo simulations, TNDM is currently undervalued. Its median fair value (P50) is calculated at $19.07, significantly above its current trading price of $15.47.
What is the bear case and bull case for TNDM?
The full Monte Carlo distribution, including our specific bear (P10) and bull (P90) target prices, along with the probability of upside, is available when you sign up for a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate TNDM's fair value?
FairCurve calculates TNDM's fair value using a sophisticated Monte Carlo simulation that models thousands of forward scenarios for the company's financials. This probabilistic approach provides a robust and dynamic fair value estimate.
How can I track TNDM's fair value as it changes?
You can add TNDM to your free FairCurve watchlist to receive daily fair-value updates. FairCurve will also instantly re-value TNDM's fair value when new earnings data is released.